[ad_1] Despite calls from some analysts to reconsider tech stocks, Deuterium Capital's John Ricciardi says it's not yet time to…
[ad_1] A trader works on the floor of the New York Stock Exchange (NYSE), June 27, 2022.Brendan McDermid | ReutersThere's…
[ad_1] The pace of biotech deals is likely to pick up, but investors should think about smaller targets, said Wells…